Publications in collaboration with researchers from London Chest Hospital (1)

1992

  1. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: A multicenter, randomized, double-blind placebo-controlled trial

    Circulation, Vol. 86, Núm. 1, pp. 100-110